Catalyst Wire Dossier Catalyst Wire Dossier

Ravicti

glycerol phenylbutyrate
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Ravicti, covering 2013-09-24 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI) [Phase 2]

See pricing